94
Views
6
CrossRef citations to date
0
Altmetric
Original Research

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis

, , , , , , , , , & show all
Pages 553-563 | Published online: 28 Jun 2013

References

  • Sherman M Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis Semin Liver Dis 2010 30 1 3 16 20175029
  • Byrne CD Olufadi R Bruce KD Cagampang FR Ahmed MH Metabolic disturbances in non-alcoholic fatty liver disease Clin Sci (Lond) 2009 116 7 539 564 19243311
  • Lewis JR Mohanty SR Nonalcoholic fatty liver disease: a review and update Dig Dis Sci 2010 55 3 560 578 20101463
  • Hernandez-Gea V Friedman SL Pathogenesis of liver fibrosis Annu Rev Pathol 2011 6 425 456 21073339
  • Roderfeld M Hemmann S Roeb E Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs) Z Gastroenterol 2007 45 1 25 33 17236118
  • Friedman SL Mechanisms of hepatic fibrogenesis Gastroenterology 2008 134 6 1655 1669 18471545
  • Hemmann S Graf J Roderfeld M Roeb E Expression of MMPs and TIMPs in liver fibrosis – a systematic review with special emphasis on anti-fibrotic strategies J Hepatol 2007 46 5 955 975 17383048
  • Rubbo H Radi R Trujillo M Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: Formation of novel nitrogen-containing oxidized lipid derivatives J Biol Chem 1994 269 42 26066 26075 7929318
  • Ignarro LJ Napoli C Loscalzo J Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ Res 2002 90 1 21 28 11786514
  • Williams DL A chemist’s view of the nitric oxide story Org Biomol Chem 2003 1 3 441 449 12926240
  • Aitio M N-acetylcysteine – passe-partout or much ado about nothing? Br J Clin Pharmacol 2006 61 1 5 15 16390346
  • Ricardo KF Shishido SM de Oliveira MG Krieger MH Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats Nitric Oxide 2002 7 1 57 66 12175821
  • de Oliveira MG Shishido SM Seabra AB Morgon NH Thermal stability of primary S-nitrosothiols: roles of autocatalysis and structural effects on the rate of nitric oxide release J Phys Chem A 2002 106 38 8963 8970
  • Oliveira CP Simplicio FI de Lima VM Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats World J Gastroenterol 2006 12 12 1905 1911 16609997
  • Simplicio FI Seabra AB de Souza GFP de Oliveira MG In vitro inhibition of linoleic acid peroxidation by primary S-nitrosothiols J Braz Chem Soc 2010 10 21 1885 1895
  • Oliveira CP de Lima VM Simplicio FI Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment J Am Coll Nutr 2008 27 2 299 305 18689562
  • Oliveira CP Alves VA Lima VM Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice Biochem Pharmacol 2007 74 2 290 297 17524368
  • de Oliveira CP Stefano JT de Lima VM Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice J Hepatol 2006 45 5 725 733 16935387
  • de Lima VM Oliveira CP Alves VA A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma J Hepatol 2008 49 6 1055 1061 18929425
  • Cogliati B Pereira Hde M Dagli ML Parra OM Silva JR Hernandez-Blazquez FJ Hepatotrophic factors reduce hepatic fibrosis in rats Arq Gastroenterol 2010 47 1 79 85 20520980
  • Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001 25 4 402 408 11846609
  • Timerghazin QK Peslherbe GH English AM Resonance description of S-nitrosothiols: insights into reactivity Org Lett 2007 9 16 3049 3052 17616141
  • Martínez V Wang L Rivier JE Vale W Taché Y Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2 J Pharmacol Exp Ther 2002 301 2 611 617 11961064
  • Gaston B Nitric oxide and thiol groups Biochim Biophys Acta 1999 1411 2 323 333 10320666
  • Stefano JT Cogliati B Santos F S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro Nitric Oxide 2011 25 3 360 365 21820071
  • James J Bosch KS Aronson DC Houtkooper JM Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver Liver 1990 10 1 1 5 2308475
  • Vercelino R Crespo I de Souza GF S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats J Mol Med (Berl) 2010 88 4 401 411 20062961
  • Iredale JP Benyon RC Pickering J Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 1998 102 3 538 549 9691091
  • Issa R Zhou X Constandinou CM Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking Gastroenterology 2004 126 7 1795 1808 15188175
  • Ramachandran P Iredale JP Reversibility of liver fibrosis Ann Hepatol 2009 8 4 283 291 20009126
  • Wang Z Juttermann R Soloway PD TIMP-2 is required for efficient activation of proMMP-2 in vivo J Biol Chem 2000 275 34 26411 26415 10827175
  • Benyon RC Arthur MJ Extracellular matrix degradation and the role of hepatic stellate cells Semin Liver Dis 2001 21 3 373 384 11586466
  • Issa R Zhou X Trim N Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration FASEB J 2003 17 1 47 49 12475903
  • Okazaki I Watanabe T Hozawa S Niioka M Arai M Maruyama K Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery Keio J Med 2001 50 2 58 65 11450593
  • Ueberham E Löw R Ueberham U Schönig K Bujard H Gebhardt R Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis Hepatology 2003 37 5 1067 1078 12717387
  • Knittel T Mehde M Grundmann A Saile B Scharf JG Ramadori G Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat Histochem Cell Biol 2000 113 6 443 453 10933221
  • Roderfeld M Weiskirchen R Wagner S Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice FASEB J 2006 20 3 444 454 16507762
  • Zhou X Murphy FR Gehdu N Zhang J Iredale JP Benyon RC Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells J Biol Chem 2004 279 23 23996 234006 15044441
  • Galicia-Moreno M Rodríguez-Rivera A Reyes-Gordillo K N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress Eur J Gastroenterol Hepatol 2009 21 8 908 914 19398917
  • Baumgardner JN Shankar K Hennings L Albano E Badger TM Ronis MJ N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis J Nutr 2008 138 10 1872 1879 18806095
  • Ekstedt M Franzén LE Mathiesen UL Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 2006 44 4 865 873 17006923
  • Argo CK Caldwell SH Epidemiology and natural history of nonalcoholic steatohepatitis Clin Liver Dis 2009 13 4 511 531 19818302